TY - JOUR
T1 - An analysis of communication following newborn screening for cystic fibrosis
AU - Dillard, James Price
AU - Carson, Christine L.
AU - Bernard, Carolynne Jane
AU - Laxova, Anita
AU - Farrell, Phillip M.
N1 - Funding Information:
Preparation of this manuscript was supported by the National Institute on Diabetes, Digestive, and Kidney Diseases and by the National Institute for Human Genome Research (R01 DK34108–16).
PY - 2004
Y1 - 2004
N2 - With the tremendous expansion of knowledge that will come from advances in the Human Genome Project, the question of how to effectively communicate genetic risk information will assume increasing importance. This article reports research intended to provide a descriptive foundation for future inquiry. Drawing on information from medical professionals and videotaped interactions of families whose infant has tested positive for cystic fibrosis, the authors present an analysis of the phases of communication following newborn screening. From this analysis, it can be seen that genetic counseling is best viewed as part of a larger process of risk communication.
AB - With the tremendous expansion of knowledge that will come from advances in the Human Genome Project, the question of how to effectively communicate genetic risk information will assume increasing importance. This article reports research intended to provide a descriptive foundation for future inquiry. Drawing on information from medical professionals and videotaped interactions of families whose infant has tested positive for cystic fibrosis, the authors present an analysis of the phases of communication following newborn screening. From this analysis, it can be seen that genetic counseling is best viewed as part of a larger process of risk communication.
UR - http://www.scopus.com/inward/record.url?scp=2442511807&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442511807&partnerID=8YFLogxK
U2 - 10.1207/s15327027hc1602_4
DO - 10.1207/s15327027hc1602_4
M3 - Article
C2 - 15090285
AN - SCOPUS:2442511807
SN - 1041-0236
VL - 16
SP - 197
EP - 205
JO - Health Communication
JF - Health Communication
IS - 2
ER -